May 7 (Reuters) - Noxopharm Ltd NOX.AX :
* VEYONDA FDA APPROVED TRIAL TO COMMENCE-NOX.AX
* U.S. FDA APPROVED IND APPLICATION FOR VEYONDA IN COMBINATION WITH DOXORUBICIN FOR PATIENTS WITH SOFT TISSUE SARCOMAS
May 7 (Reuters) - Noxopharm Ltd NOX.AX :
* VEYONDA FDA APPROVED TRIAL TO COMMENCE-NOX.AX
* U.S. FDA APPROVED IND APPLICATION FOR VEYONDA IN COMBINATION WITH DOXORUBICIN FOR PATIENTS WITH SOFT TISSUE SARCOMAS